249 related articles for article (PubMed ID: 36965591)
1. Small airways disease in patients with alpha-1 antitrypsin deficiency.
Toumpanakis D; Usmani OS
Respir Med; 2023 May; 211():107222. PubMed ID: 36965591
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
3. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
[TBL] [Abstract][Full Text] [Related]
4. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary manifestations of alpha 1 antitrypsin deficiency.
Mulkareddy V; Roman J
Am J Med Sci; 2024 Jul; 368(1):1-8. PubMed ID: 38599244
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
7. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
8. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
Kokturk N; Khodayari N; Lascano J; Riley EL; Brantly ML
Respir Res; 2023 Feb; 24(1):40. PubMed ID: 36732772
[TBL] [Abstract][Full Text] [Related]
9. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.
Esquinas C; Janciauskiene S; Gonzalo R; Mas de Xaxars G; Olejnicka B; Belmonte I; Barrecheguren M; Rodriguez E; Nuñez A; Rodriguez-Frias F; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():3381-3390. PubMed ID: 29238183
[TBL] [Abstract][Full Text] [Related]
10. Alpha1-antitrypsin deficiency: An updated review.
Mornex JF; Traclet J; Guillaud O; Dechomet M; Lombard C; Ruiz M; Revel D; Reix P; Cottin V
Presse Med; 2023 Sep; 52(3):104170. PubMed ID: 37517655
[TBL] [Abstract][Full Text] [Related]
11. The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency.
Campos MA; Diaz AA
Chest; 2018 May; 153(5):1240-1248. PubMed ID: 29175361
[TBL] [Abstract][Full Text] [Related]
12. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
13. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
[TBL] [Abstract][Full Text] [Related]
16. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
[TBL] [Abstract][Full Text] [Related]
17. Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0
Karadoğan D; Şahin Ü; Dreger B; Grandoso L; Osaba L
BMC Pulm Med; 2024 Feb; 24(1):91. PubMed ID: 38383302
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
19. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.
Silva D; Oliveira MJ; Guimarães M; Lima R; Gomes S; Seixas S
Respir Med; 2016 Jul; 116():8-18. PubMed ID: 27296815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
